Systematic review of fever, febrile convulsions and serious adverse events following administration of inactivated trivalent influenza vaccines in children

Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children

(2014) Rebecca C. Brady et al.   VACCINE

Risk of Fever After Pediatric Trivalent Inactivated Influenza Vaccine and 13-Valent Pneumococcal Conjugate Vaccine

(2014) Melissa S. Stockwell et al.   JAMA Pediatrics

Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents

(2013) Stephen B. Lambert et al.   Influenza and Other Respiratory Viruses

The risk of fever following one dose of trivalent inactivated influenza vaccine in children aged ≥6 months to

(2013) Marlena C. Kaczmarek et al.   VACCINE

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

(2013) Noris Pavia-Ruz et al.   Human Vaccines & Immunotherapeutics

Paediatric influenza vaccination program suspension: effect on childhood vaccine uptake

(2012) Donna B. Mak et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH

H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study

(2012) Woolf T. Walker et al.   CLINICAL INFECTIOUS DISEASES

Increased reactions to pediatric influenza vaccination following concomitant pneumococcal vaccination

(2012) Paul G. Van Buynder et al.   Influenza and Other Respiratory Viruses

Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations

(2012) S. E. Frey et al.   JOURNAL OF INFECTIOUS DISEASES

More on Influenza Vaccine in Young Children

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: The importance of routine active safety surveillance

(2012) Helen Petousis-Harris et al.   VACCINE

Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine

(2012) Eugene Maraskovsky et al.   VACCINE

Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010–2011

(2012) Alison Tse et al.   VACCINE

Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink

(2011) Jason M. Glanz   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis

(2011) J. Kevin Yin et al.   Influenza and Other Respiratory Viruses

Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children

(2011) Daniel F. Hoft et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Immunogenicity of a New Trivalent Inactivated Split-virus Influenza Vaccine in Healthy Korean Children: A Randomized, Double-blinded, Active-controlled, Phase III Study

(2011) Jin-Han Kang et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies

(2011) Alex J Mitchell et al.   LANCET ONCOLOGY

Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children

(2011) Timo Vesikari et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunogenicity of Trivalent Influenza Vaccine in Extremely Low-birth-weight, Premature Versus Term Infants

(2011) Carl T. DʼAngio et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Influenza Vaccine Safety in Children Less Than 5 Years Old

(2011) Nicholas Wood et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Randomized Controlled Trial of Dose Response to Influenza Vaccine in Children Aged 6 to 23 Months

(2011) D. M. Skowronski et al.   PEDIATRICS

Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine

(2011) P. K. Armstrong et al.   BMJ Open

Protective Efficacy of Seasonal Influenza Vaccination against Seasonal and Pandemic Influenza Virus Infection during 2009 in Hong Kong

(2010) Benjamin J. Cowling et al.   CLINICAL INFECTIOUS DISEASES

A Phase III Evaluation of Immunogenicity and Safety of Two Trivalent Inactivated Seasonal Influenza Vaccines in US Children

(2010) Roger Baxter et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence

(2010) T. Vesikari et al.   PEDIATRICS

A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6–35 months

(2010) Susanna Esposito et al.   VACCINE

Impact of influenza infection on children's hospital admissions during two seasons in Athens, Greece

(2010) Z. Sakkou et al.   VACCINE

Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children

(2009) Terry Nolan et al.   Influenza and Other Respiratory Viruses

Efficacy of Injectable Trivalent Virosomal-Adjuvanted Inactivated Influenza Vaccine in Preventing Acute Otitis Media in Children With Recurrent Complicated or Noncomplicated Acute Otitis Media

(2009) Paola Marchisio et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Trivalent Inactivated Influenza Virus Vaccine Given to Two-Month-Old Children

(2009) Emmanuel B. Walter et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant

(2009) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months

(2009) James C. King et al.   VACCINE

MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination

(2009) T. Vesikari et al.   VACCINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

(2008) R. Stasi et al.   BLOOD

Systematic Review and Meta-analysis of Ovarian Cancers: Estimation of Microsatellite-High Frequency and Characterization of Mismatch Repair Deficient Tumor Histology

(2008) T. Pal et al.   CLINICAL CANCER RESEARCH

Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China

(2008) Feng Cai Zhu et al.   VACCINE

Safe vaccination of children with a virosomal adjuvanted influenza vaccine

(2008) Valérie Künzi et al.   VACCINE